Mostrando 8 resultados de: 8
Filtros aplicados
Publisher
Bionatura(4)
Pharmaceutics(2)
Biotecnologia Aplicada(1)
Electronic Journal of Biotechnology(1)
Área temáticas
Farmacología y terapéutica(4)
Ingeniería química(2)
Medicina y salud(2)
Microorganismos, hongos y algas(2)
Artes(1)
Área de conocimiento
Biotecnología(2)
Bioquímica(1)
Ciencia de materiales(1)
Enfermedad cardiovascular(1)
Ensayo clínico(1)
Clinical Research & Clinical Trials Challenges and Perspectives
OtherAbstract:Palabras claves:Autores:Thelvia I. Ramos GómezFuentes:scopusForms and methods for interferon’s encapsulation
ReviewAbstract: Interferons (IFNs) are cytokines involved in the immune response that act on innate and adaptive immPalabras claves:Antiproliferative, antiviral, Drug delivery system, Encapsulate IFNs, formulation, IFN-α, IFN-β, IFN-γ, Immunomodulator, interferons, Liposomes, Microparticles, Nanoparticles, Pegylation, Polymeric micellesAutores:Leandro Santiago Padilla, Parra N.C., Santana S.P., Santiago Nelson Vispo, Thelvia I. Ramos Gómez, Toledo Alonso J.R., Villacis-Aguirre C.A.Fuentes:googlescopusFrom the laboratory to the industry: Enzymatic production and applications of shortchain fructooligosaccharides (FOS). Recent advances and current perspectives
ReviewAbstract: The production of high yields of oligosaccharides of specific chain length from simple raw materialsPalabras claves:Enzymatic production, Enzymes, oligosaccharidesAutores:L. K. Ponce, Luis E. Trujillo, Rodrigo Ávalos, Thelvia I. Ramos Gómez, Vanessa E. MarcilloFuentes:scopusFSH in bovine superovulation
ReviewAbstract: Bovine follicle stimulating hormone (FSH) is the hormone mainly used for superovulation treatments.Palabras claves:bovine, Fsh, Recombinant, SuperovulationAutores:Chávez S.P.J., Franco C.D.M., Thelvia I. Ramos Gómez, Toledo J.R., Valeria M.Bautista VegaFuentes:scopusEstablishment of a production process for a novel vaccine candidate against Lawsonia intracellularis
ArticleAbstract: Background: Lawsonia intracellularis remains a problem for the swine industry worldwide. Previously,Palabras claves:fed-batch culture, Immune response, LAWSONIA INTRACELLULARIS, Proliferative enteropathy, Recombinant vaccineAutores:Acosta J., Altamirano C., González A., Gutiérrez N., Montesino R., Ramos E., S. Salazar, Sanchez O., Thelvia I. Ramos Gómez, Toledo J.R.Fuentes:scopusLOX-1 in cardiovascular diseases, future therapeutic perspectives
ArticleAbstract: The low-density oxidized lipoprotein lectin-1 (LOX-1) receptor, also known as OLR-1, is a scavengerPalabras claves:atherosclerosis, dyslipidemia, endothelial dysfunction, LOX-1 lectin-like OxLDL receptor 1, Oxidized low-density lipoprotein, Soluble LOX-1Autores:Alonso J.R.T., Thelvia I. Ramos GómezFuentes:scopusThe Hitchhiker’s Guide to Human Therapeutic Nanoparticle Development
ReviewAbstract: Nanomedicine plays an essential role in developing new therapies through novel drug delivery systemsPalabras claves:clinical trials, Immunotoxicity, Nanomedicine, Nanoparticles, pharmacokinetics, Preclinical, Regulatory aspectsAutores:Altamirano C., Katherine V. López-Aguilar, Leandro Santiago Padilla, Santiago Nelson Vispo, Thelvia I. Ramos Gómez, Toledo J.R., Villacis-Aguirre C.A.Fuentes:scopusVariable level expression of hepatitis C virus core protein in a prokaryotic system. Analysis of the humoral response against it in rabbits
ArticleAbstract: Experimental evidence suggests that the hepatitis C virus (HCV) core protein has several biologicalPalabras claves:E. coli, expression, HCV, Hepatitis C virus, Immunogenicity, Nucleocapsid core protein, purificationAutores:Acosta-Rivero N., Dueñas-Carrera S., Garcia C., Guerra I., Lorenzo L.J., Morales J., Pena M., Thelvia I. Ramos GómezFuentes:googlescopus